Influenza A viruses target type II pneumocytes in the human lung

Journal of Infectious Diseases

Volumn 206, Issue 11, 2012, Pages 1685-1694

  Weinheimer, Viola K ^a   Becher, Anne ^b   Tönnies, Mario ^c   Holland, Gudrun ^a   Knepper, Jessica ^a   Bauer, Torsten T ^c   Schneider, Paul ^d   Neudecker, Jens ^b   Rückert, Jens C ^b   Szymanski, Kolja ^b   Temmesfeld Wollbrueck, Bettina ^b   Gruber, Achim D ^e   Bannert, Norbert ^a   Suttorp, Norbert ^b   Hippenstiel, Stefan ^b   Wolff, Thorsten ^a   Hocke, Andreas C ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Chest Hospital Heckeshorn   (Germany)

^d DRK Clinics   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; VIRAL TROPISM; VIRUS REPLICATION; VIRUS VIRULENCE;

CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LUNG; MACROPHAGES, ALVEOLAR; PNEUMOCYTES; TISSUE CULTURE TECHNIQUES; VIRAL TROPISM; VIRULENCE; VIRUS REPLICATION;

EID: 84869025948     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis455     Document Type: Article

References (50)

1. Wright PF, Neumann, G, Yoshihiro K. Orthomyxoviruses. In: Fields Virology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins. 2007:1691-740.
2. Thompson MG, Shay DK, Zhou H, et al. Centers for Disease Control and Prevention. Morb Mortal Wkly Rep 2010; 59:1057-62.
3. Patterson KD, Pyle GF. The geography and mortality of the 1918 influenza pandemic. Bull Hist Med 1991; 65:4-21.
4. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009; 459:931-9.
5. Beare AS, Webster RG. Replication of avian influenza viruses in humans. Arch Virol 1991; 119:37-42.
6. Taubenberger JK, Kash JC. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 2010; 7:440-51.
7. Ito T, Couceiro JN, Kelm S, et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 1998; 72:7367-73.
8. Couceiro JN, Paulson JC, Baum LG. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res 1993; 29:155-65.
9. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006; 440:435-6.
10. van Riel D, Munster VJ, de Wit E, et al. H5N1 virus attachment to lower respiratory tract. Science 2006; 312:399.
11. van Riel D, Munster VJ, de Wit E, et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 2007; 171:1215-23.
12. Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 2008; 172:1155-70.
13. Yu H, Gao Z, Feng Z, et al. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One 2008; 3:e2985.
14. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005; 6:135.
15. Cheung CY, Poon LL, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360:1831-7.
16. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12:1203-7.
17. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004; 363:617-9.
18. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008; 4:e1000115.
19. Deng R, Lu M, Korteweg C, et al. Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients. J Pathol 2008; 216:328-36.
20. Droebner K, Reiling SJ, Planz O. Role of hypercytokinemia in NFkappaB p50-deficient mice after H5N1 influenza A virus infection. J Virol 2008; 82:11461-6.
21. Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A 2007; 104:12479-81.
22. Szretter KJ, Gangappa S, Lu X, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007; 81:2736-44.
23. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A 2009; 106:3455-60.
24. Herzog EL, Brody AR, Colby TV, Mason R, Williams MC. Knowns and unknowns of the alveolus. Proc Am Thorac Soc 2008; 5:778-82.
25. Fuchs S, Hollins AJ, Laue M, et al. Differentiation of human alveolar epithelial cells in primary culture: morphological characterization and synthesis of caveolin-1 and surfactant protein-C. Cell and Tissue Res 2003; 311:31-45.
26. Stevens A, Lowe JS. Human histology. 2nd ed. London: Chapman & Hall, 1996.
27. Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 2007; 370:1137-45.
28. Guarner J, Shieh WJ, Dawson J, et al. Immunohistochemical and in situ hybridization studies of influenza A virus infection in human lungs. Am J Clin Pathol 2000; 114:227-33.
29. Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine 2008; 26(Suppl 4):D59-66.
30. Zielecki F, Semmler I, Kalthoff D, et al. Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. J Virol 2010; 84:10708-18.
31. Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature 2007; 447:279-83.
32. Watanabe T, Watanabe S, Kawaoka Y. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 2010; 7:427-39.
33. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 2007; 44:1084-8.
34. Dobrovolny HM, Baron MJ, Gieschke R, Davies BE, Jumbe NL, Beauchemin CA. Exploring cell tropism as a possible contributor to influenza infection severity. PLoS One 2010; 5:e13811.
35. Ibricevic A, Pekosz A, Walter MJ, et al. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol 2006; 80:7469-80.
36. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci U S A 2004; 101:4620-4.
37. Mason RJ. Biology of alveolar type II cells. Respirology 2006; 11 (Suppl):S12-5.
38. Shieh WJ, Blau DM, Denison AM, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 2010; 177:166-75.
39. Zhang J, Zhang Z, Fan X, et al. 2009 pandemic H1N1 influenza virus replicates in human lung tissues. J Infect Dis 2010; 201:1522-6.
40. Chow KC, Hsiao CH, Lin TY, Chen CL, Chiou SH. Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung. Am J Clin Pathol 2004; 121:574-80.
41. Shieh WJ, Hsiao CH, Paddock CD, et al. Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. Hum Pathol 2005; 36:303-9.
42. Ye J, Zhang B, Xu J, et al. Molecular pathology in the lungs of severe acute respiratory syndrome patients. Am J Pathol 2007; 170:538-45.
43. Lee SM, Chan RW, Gardy JL, et al. Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro. Respir Res 2010; 11:147.
44. Yu WC, Chan RW, Wang J, et al. Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. J Virol 2011; 85:6844-55.
45. van Riel D, Leijten LM, van der Eerden M, et al. Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction. PLoS Pathog 2011; 7: e1002099.
46. Wolff T, Ludwig S. Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences. J Interferon Cytokine Res 2009; 29:549-57.
47. Chan MC, Chan RW, Yu WC, et al. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 2010; 176:1828-40.
48. Osterlund P, Pirhonen J, Ikonen N, et al. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 2010; 84:1414-22.
49. Ramos I, Bernal-Rubio D, Durham N, et al. Effects of receptor binding specificity of avian influenza virus on the human innate immune response. J Virol 2011; 85:4421-31.
50. Wang J, Nikrad MP, Phang T, et al. Innate immune response to influenza A virus in differentiated human alveolar type II cells. Am J Respir Cell Mol Biol 2011; 45:582-91.